Fresh surgical biopsy specimens were obtained from 28 patients with peritoneal carcinomatosis from colon cancer. TS, TP, DPD, MDR1, MRP-1, MGMT, BRCA1, ERCC1, GSTP1, and XPD gene expression levels were determined by real-time reverse transcription polymerase chain reaction. An in vitro chemosensitivity test was used to define a sensitivity or resistance profile to the drugs used to treat each patient.
Expression levels of the genes analyzed were generally poorly related to each other. TS and ERCC1 expression was inversely related to response to 5-FU-and/or oxaliplatin-containing regimens. Significant predictivity in terms of sensitivity but poor predictivity of resistance (56.2 % ) (P = .037) were observed for ERCC1 expression (90 % ), and high predictivity of resistance (100 % ) but very low predictivity of sensitivity (40 % ) (P = .014) were registered for TS. The best overall and significant predictivity was observed for chemosensitivity test results (62.5 % sensitivity and 89 % resistance; P = .005).
Sensitivity and resistance to drugs used in vivo was better defined by the chemosensitivity test than by biomarker expression.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址:北京市海淀区学院路29号 邮编:100083 电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700 |